FDA Approves First Biosimilar
In a landmark decision, FDA approved Zarxio, making it the first biosimilar product in the United States.

Should the Term “Key Opinion Leaders” be Replaced?
Survey reveals pharmaceutical and medical attitudes towards “KOL” terminology.

Drug Spending Highest Since 2003, Says Report
Drug spending rose last year at the highest rate since 2003, driven by specialty medicines, according to a report from pharmacy benefit manager Express Scripts.

FDA Approves Astellas’ Anti-Fungal Drug
Astellas Pharma announced that it received FDA approval for its treatment of fatal invasive fungal infections in patients with blood cancers.

Zogenix Ditches Its Controversial Drug Zohydro
Zogenix agreed to sell Zohydro, its controversial pain medication, to Pernix for $100 million.

Advertisement: How to Streamline your Quality & Compliance Processes with Risk Assessment In this white paper, learn about the best practices to using Risk Assessment in a QMS, how to identify critical events, mitigate the risk, and prevent re-occurrence of these events, and how building a risk matrix will facilitate the decision making process. Download White Paper Now

Mallinckrodt Accents Critical Care With Ikaria Acquisition
Mallinckrodt Pharmaceuticals has bought Ikaria, a privately-held critical care company, for $2.3 billion.

Advertisement: Learn best practices of successful tableting, and tips and tricks for avoiding common manufacturing problems at Basics of Tablet Manufacturing and Troubleshooting, March 24-26, 2015. Reserve your spot for this hands-on course taught by Natoli Engineering's technical services and training experts that offers knowledge far beyond what can be learned in textbooks and webinars. Learn More

AbbVie to Acquire Pharmacyclics for $21 billion
AbbVie's acquisition of Pharmacyclics establishes the combined company as an emerging leader in hematological oncology.

Advertisement: Vetter Development Service Chicago: New manufacturing options tailored to your drug product needs This podcast showcases Vetter's capabilities in its Chicago development service site. Additionally, it will inform you about the completed site expansion with the addition of a third cleanroom. Clinical syringe projects are now being accepted at this facility. Learn More

Baxter Builds Immunology Portfolio by Acquiring Autoimmune Specialist
Baxter has bought SuppreMol, a German biopharmaceutical company that focuses on autoimmune treatments, for €200 million ($225 million USD).

Advertisement: Charged Aerosol Detection (CAD) applies to a broad range of HPLC separations and possesses a number of desirable characteristics for detection and quantitation of various compounds including those without UV absorbing chromophores. The many benefits of CAD, make it an attractive detector for use in pharmaceutical drug development. Metrics Contract Services has significant experience using CAD technology throughout the drug development process. Learn More

WHO Launches Ebola Vaccine Efficacy Trial
The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.

BASF Shores Up Specialty Amines Supply
BASF is expanding its Verbund site in Ludwigshafen to include production capacity for about 20 specialty amines.

Advertisement: Fundamentals of Spray-Dried Dispersion Technology Live broadcast on: March 19th, 2015 at 11AM ET Spray-dried dispersion technology is a proven approach to improve the dissolution rate and bioavailability of low solubility compounds, and helps to bring new medicines to market. Attend this webinar to learn the fundamentals of spray-dried dispersion formulation selection, process development, stability, scale-up, and performance considerations. Register free: www.pharmtech.com/spray

Patheon Acquires IRIX Pharmaceuticals
Patheon cites expanded API services with acquisition of IRIX Pharmaceuticals.

Advertisement: Enhancing Quality and Process Efficiency using Continuous Manufacturing Technology for Drug Substance and Drug Product On Demand Click Here to Register free.